Application Sponsors
ANDA 211398 | NOVITIUM PHARMA | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
Application Products
001 | CAPSULE;ORAL | 5MG | 0 | MELOXICAM | MELOXICAM |
002 | CAPSULE;ORAL | 10MG | 0 | MELOXICAM | MELOXICAM |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2018-11-15 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2022-10-11 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
NOVITIUM PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 211398
[companyName] => NOVITIUM PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"MELOXICAM","activeIngredients":"MELOXICAM","strength":"5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"MELOXICAM","activeIngredients":"MELOXICAM","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/15\/2018","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2018-11-15
)
)